{"SPADE_N_14076": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14076", "Peptide Name": "Lan-Df (natural AMPs; nisin-like, lantibiotic, type 1, class 1 bacteriocin, Gram-positive bacteria, prokaryotes; UCSS1b)", "Source": "Dorea formicigenerans:human microbiota:Gut", "Family": "Not found", "Gene": "Not found", "Sequence": "YKSKSVCTPGCPTGILMTCPLKTATCGCHITGK", "Sequence Length": 33, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3401.1, "PI": 9.02, "Hydrophobicity": 0.14, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Zhang ZJ, Wu C, Moreira R, Dorantes D, Pappas T, Sundararajan A, Lin H, Pamer EG, van der Donk WA.2024", "Reference": "ACS Chem Biol. 2024 Jan 31. doi: 10.1021/acschembio.3c00577.PubMed", "Title": "Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals."}], "Frequent Amino Acids": "TCG", "Absent Amino Acids": "DEFNOQRUW", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 21, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Discovery: applied RODEO to the public RefSeq database to identify novel nisin-like class I lantibiotics encoded in gut microbial genomes.Sequence analysis: APD analysis reveals that this sequence is similar (96.97%) toNisin Owhere A is changed to V.Activity: Active against E. faecium ATCC700221 (MIC above 1-10 uM), Methicillin-resistant S. aureus USA300 MRSA (MIC 1-10 uM), Methicillin-resistant S. epidermidis SK135 (MIC above 1-10 uM), L. monocytogenes 10403S (MIC 10 uM), and C. difficile VPI10463 (MIC 1 uM), A. hadrus MSK.14.23 (MIC 0.01-0.1 uM), B. obeum MSK.18.40 (MIC 0.01 uM), B. luti MSK.20.18 (MIC 0.001-0.01 uM), E. ramosum MSK.23.96 (MIC 10 uM), D. formicogenerans MSK.17.61 (MIC 0.01 uM), C. comes MSK.11.23 (MIC 0.1-1 uM), C. eutactus MSK.18.32 (MIC 0.1 uM), and F. fissicatena MSK.9.3 (MIC 0.01-0.1 uM).Recombinant production:bacteria:Escherichia coli: expressed in E. coli followed by isolation and purification. Est.2024; 4/2024", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18839", "Similarity": 0.9696969696969697, "Sequence": "YKSKSACTPGCPTGILMTCPLKTATCGCHITGK"}, {"SPADE_ID": "SPADE_N_15413", "Similarity": 0.9333333333333333, "Sequence": "YKSKVCTPGCPTGILMCPLKTATCGCHIGK"}, {"SPADE_ID": "SPADE_N_15411", "Similarity": 0.9, "Sequence": "YKSKACTPGCPTGILMCPLKTATCGCHIGK"}]}}}